Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 0775)

ANNUAL GENERAL MEETING HELD ON 11TH MAY, 2017 - POLL RESULTS

The poll results in respect of the resolutions proposed at the Annual General Meeting (the "AGM") of CK Life Sciences Int'l., (Holdings) Inc. (the "Company") held on 11th May, 2017 are as follows:

Ordinary Resolutions

No. of Votes (Approx. %)

For

Against

1

To receive the audited Financial Statements, the Report of the Directors and the Independent Auditor's Report for the year ended 31st December, 2016.

7,342,167,711

(99.999471%)

38,850

(0.000529%)

The resolution was duly passed as an ordinary resolution.

2

To declare a final dividend.

7,342,220,711

(99.999471%)

38,850

(0.000529%)

The resolution was duly passed as an ordinary resolution.

3(1)

To elect Mr. Yu Ying Choi, Alan Abel as Director.

7,290,258,234

(99.291347%)

52,031,327

(0.708653%)

The resolution was duly passed as an ordinary resolution.

3(2)

To elect Dr. Chu Kee Hung as Director.

7,290,264,234

(99.291429%)

52,025,327

(0.708571%)

The resolution was duly passed as an ordinary resolution.

3(3)

To elect Mr. Peter Peace Tulloch as Director.

7,340,688,711

(99.978769%)

1,558,850

(0.021231%)

The resolution was duly passed as an ordinary resolution.

4

To appoint Messrs. Deloitte Touche Tohmatsu as Auditor and authorise the Directors to fix their remuneration.

7,342,142,711

(99.997918%)

152,850

(0.002082%)

The resolution was duly passed as an ordinary resolution.

5(1)

Ordinary Resolution No. 5(1) of the Notice of Annual General

7,234,037,768

108,257,793

Meeting

(98.525559%)

(1.474441%)

(To give a general mandate to the Directors to issue additional

shares of the Company).

The resolution was duly passed as an ordinary resolution.

5(2)

Ordinary Resolution No. 5(2) of the Notice of Annual General

7,342,058,711

242,850

Meeting

(99.996692%)

(0.003308%)

(To give a general mandate to the Directors to buy back shares of

the Company).

The resolution was duly passed as an ordinary resolution.

5(3)

Ordinary Resolution No. 5(3) of the Notice of Annual General

7,234,658,768

107,625,793

Meeting

(98.534165%)

(1.465835%)

(To extend the general mandate granted to the Directors pursuant

to Ordinary Resolution No. 5(1) to issue additional shares of the

Company).

The resolution was duly passed as an ordinary resolution.

As at the date of the AGM, the issued share capital of the Company was 9,611,072,400 ordinary shares of HK$0.10 each (the "Shares"), being the total number of Shares entitling the holders thereof (the "Shareholders") to attend and vote for or against all the resolutions proposed at the AGM. There were no Shares entitling the Shareholders to attend and abstain from voting in favour pursuant to Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"). There were no Shareholders that are required under the Listing Rules to abstain from voting.

Computershare Hong Kong Investor Services Limited, the Branch Share Registrar of the Company, acted as scrutineers for the poll at the AGM.

For and on behalf of

CK Life Sciences Int'l., (Holdings) Inc. Eirene Yeung

Company Secretary

Hong Kong, 11th May, 2017

As at the date of this document, the Executive Directors of the Company are Mr. Li Tzar Kuoi, Victor (Chairman), Mr. Kam Hing Lam, Mr. Ip Tak Chuen, Edmond, Mr. Yu Ying Choi, Alan Abel and Dr. Chu Kee Hung; and the Non-executive Directors are Mr. Peter Peace Tulloch, Mrs. Kwok Eva Lee (Independent Non-executive Director), Mr. Colin Stevens Russel (Independent Non-executive Director) and Mr. Kwan Kai Cheong (Independent Non-executive Director).

CK Life Sciences International Holdings Inc. published this content on 11 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 May 2017 10:01:15 UTC.

Original documenthttp://www.ck-lifesciences.com/uploaded_files/images/listing/755/content_file_lang1.pdf

Public permalinkhttp://www.publicnow.com/view/EB1FC736C5E89671A651B1D6FF5A3C529AB08BDE